Hermes Florez to Metformin
This is a "connection" page, showing publications Hermes Florez has written about Metformin.
Connection Strength
3.953
-
Metformin and ageing: improving ageing outcomes beyond glycaemic control. Diabetologia. 2017 09; 60(9):1630-1638.
Score: 0.562
-
Metabolic syndrome components and their response to lifestyle and metformin interventions are associated with differences in diabetes risk in persons with impaired glucose tolerance. Diabetes Obes Metab. 2014 Apr; 16(4):326-33.
Score: 0.433
-
Impact of lifestyle intervention and metformin on health-related quality of life: the diabetes prevention program randomized trial. J Gen Intern Med. 2012 Dec; 27(12):1594-601.
Score: 0.394
-
Circulating sex hormone binding globulin levels are modified with intensive lifestyle intervention, but their changes did not independently predict diabetes risk in the Diabetes Prevention Program. BMJ Open Diabetes Res Care. 2020 12; 8(2).
Score: 0.354
-
The Impact of Physical Activity on the Prevention of Type 2 Diabetes: Evidence and Lessons Learned From the Diabetes Prevention Program, a Long-Standing Clinical Trial Incorporating Subjective and Objective Activity Measures. Diabetes Care. 2021 01; 44(1):43-49.
Score: 0.353
-
Impact of metformin-induced gastrointestinal symptoms on quality of life and adherence in patients with type 2 diabetes. Postgrad Med. 2010 Mar; 122(2):112-20.
Score: 0.336
-
The effect of lifestyle intervention and metformin on preventing or delaying diabetes among women with and without gestational diabetes: the Diabetes Prevention Program outcomes study 10-year follow-up. J Clin Endocrinol Metab. 2015 Apr; 100(4):1646-53.
Score: 0.237
-
Propensity Score Matching to Determine the Impact of Metformin on All-Cause Mortality in Older Veterans with Diabetes Mellitus. South Med J. 2022 03; 115(3):208-213.
Score: 0.193
-
Long-term effects of lifestyle and metformin interventions in DPP on bone density. Osteoporos Int. 2021 Nov; 32(11):2279-2287.
Score: 0.183
-
Association of Intensive Lifestyle and Metformin Interventions With Frailty in the Diabetes Prevention Program Outcomes Study. J Gerontol A Biol Sci Med Sci. 2021 04 30; 76(5):929-936.
Score: 0.182
-
Optimization of Metformin in the GRADE Cohort: Effect on Glycemia and Body Weight. Diabetes Care. 2020 05; 43(5):940-947.
Score: 0.168
-
Long-Term Weight Loss With Metformin or Lifestyle Intervention in the Diabetes Prevention Program Outcomes Study. Ann Intern Med. 2019 05 21; 170(10):682-690.
Score: 0.158
-
Metformin, Lifestyle Intervention, and Cognition in the Diabetes Prevention Program Outcomes Study. Diabetes Care. 2017 07; 40(7):958-965.
Score: 0.138
-
10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet. 2009 Nov 14; 374(9702):1677-86.
Score: 0.082
-
Interaction Between Type 2 Diabetes Prevention Strategies and Genetic Determinants of Coronary Artery Disease on Cardiometabolic Risk Factors. Diabetes. 2020 01; 69(1):112-120.
Score: 0.041
-
Baseline Characteristics of Randomized Participants in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE). Diabetes Care. 2019 11; 42(11):2098-2107.
Score: 0.040
-
Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med. 2009 Jan 08; 360(2):129-39.
Score: 0.039
-
The impact of lifestyle intervention on sedentary time in individuals at high risk of diabetes. Diabetologia. 2015 Jun; 58(6):1198-202.
Score: 0.030
-
Impact of diagnosis of diabetes on health-related quality of life among high risk individuals: the Diabetes Prevention Program outcomes study. Qual Life Res. 2014 Feb; 23(1):75-88.
Score: 0.026